Does achieving an intensive versus usual blood pressure level prevent stroke?

Ann Neurol. 2012 Jan;71(1):133-40. doi: 10.1002/ana.22496. Epub 2011 Jul 27.

Abstract

Objective: The purpose of this study was to compare the impact of achieving tight versus usual systolic blood pressure (SBP) control on stroke prevention through meta-analysis of randomized controlled trials.

Methods: We searched PubMed and bibliographies of recent review articles. Relative risk with 95% confidence interval was used as a measure of the association between an active treatment group with achieved SBP <130 mmHg versus a comparator group with achieved SBP 130 to 139 mmHg, and risk of stroke after pooling data across trials.

Results: The search identified 11 studies with 42,572 participants and 794 stroke events. The final SBPs, weighted for trial size, were a mean of 126.5 mmHg in the intensive treatment arms and 132.6 mmHg in the conventional arms (mean SBP reduction, 6.1 mmHg). Achieving a tight SBP level was associated with a lower stroke risk (relative risk, 0.80; 95% confidence interval, 0.70-0.92; p < 0.01) and a lower risk of major vascular events (0.91; 0.86-0.96; p < 0.001). In subgroup analyses, subjects with risk factors but no established cardiovascular disease showed substantial reduction of future stroke risk with tight control (0.49; 0.34-0.69), but those with established cardiovascular disease at entry did not experience stroke risk reduction with tight control (0.92; 0.83-1.03).

Interpretation: Achieving an SBP <130 mmHg compared to 130 to 139 mmHg appears to provide additional stroke protection only among people with risk factors but no established cardiovascular disease.

Publication types

  • Comparative Study
  • Meta-Analysis

MeSH terms

  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use*
  • Blood Pressure / drug effects
  • Blood Pressure / physiology*
  • Humans
  • Hypertension / drug therapy
  • Hypertension / epidemiology
  • Hypertension / physiopathology
  • Randomized Controlled Trials as Topic* / methods
  • Randomized Controlled Trials as Topic* / trends
  • Stroke / epidemiology*
  • Stroke / physiopathology
  • Stroke / prevention & control*

Substances

  • Antihypertensive Agents